Clinical Trial Update: Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating LactiSal 1% Gel, LactSal 50 mg, and Clotrimazole 100 mg Tablet for vulvovaginal candidiasis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• Clotrimazole 100 mg Tablet (Clotrimazole)
• LactSal 50 mg (null)
• LactiSal 1% Gel (null)

Snippet

Sponsor: Medinova AG | Conditions: Vulvovaginal Candidiasis | Phase 3 | Status: WITHDRAWN